Policy changes related to telemedicine that were quickly implemented during the novel coronavirus pandemic (COVID-19) have created opportunities for technology-based clinical evaluation, which serves to protect patients and providers alike, while conserving personal protective equipment (PPE).

A computational method that uses hospital billing codes and electronic health records can identify genetic disease cases before clinical teams do.

Simulated electronic health records could avoid patient privacy risks and help speed discovery.

Around two-thirds of patients treated for breast cancer will have had hormone-sensitive tumors and, after their initial treatment, will be advised to undergo hormone therapy for five to 10 years to prevent recurrence.

At Vanderbilt University Medical Center (VUMC) there are about 486 distinct operational units involved in inpatient care and evaluation.

A team at Vanderbilt University Medical Center (VUMC) has developed and tested software that scans electronic health records in real time to monitor cancer patient survival (from time of diagnosis) according to which genes, if any, are found to carry mutations.

To most effectively use electronic health records for research, investigators should query multiple components of the record to identify patients with specific diseases.